KYTX
Kyverna Therapeutics, Inc.
6.40$
+3.4%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | – | – | – | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| 132.6% | – | – | – | – | – | – | – | 27.8% | – | – | – | – | – | – | – | |
| -32.6% | – | – | – | – | – | – | – | -27.8% | – | – | – | – | – | – | – | |
| 2,373.4% | – | – | – | – | – | – | – | 1,626.5% | – | – | – | – | – | – | – | |
| 705.7% | – | – | – | – | – | – | – | 373.4% | – | – | – | – | – | – | – | |
| 3,079.1% | – | – | – | – | – | – | – | 1,999.9% | – | – | – | – | – | – | – | |
| -3,111.7% | – | – | – | – | – | – | – | -2,027.7% | – | – | – | – | – | – | – | |
| 14.5% | – | – | – | – | – | – | – | 1.3% | – | – | – | – | – | – | – | |
| -3,012.8% | – | – | – | – | – | – | – | -1,852.2% | – | – | – | – | – | – | – | |
| 22.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -3,012.8% | – | – | – | – | – | – | – | -1,852.2% | – | – | – | – | – | – | – | |
| -2,865.6% | – | – | – | – | – | – | – | -1,823.1% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.